New shot for lupus enters early human testing

NCT ID NCT06625671

First seen Dec 29, 2025 · Last updated Jun 14, 2026 · Updated 26 times

Summary

This study tests a new injection called DB-2304 in healthy people and those with lupus (SLE or CLE). The main goal is to check safety and side effects. About 148 adults will take part. This is an early-stage trial to see if the drug is safe enough for further testing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Site AUS01-0

    COMPLETED

    Melbourne, Victoria, 3004, Australia

  • US02-0

    RECRUITING

    San Antonio, Texas, 78215, United States

  • US03-0

    RECRUITING

    Clearwater, Florida, 33765, United States

  • US04-0

    RECRUITING

    Irving, Texas, 75061, United States

  • US05-0

    RECRUITING

    Orlando, Florida, 32808, United States

  • US06-0

    RECRUITING

    La Palma, California, 90623, United States

  • US08-0

    NOT_YET_RECRUITING

    Syracuse, New York, 13210, United States

Conditions

Explore the condition pages connected to this study.